Compass Therapeutics CMPX

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Biological Products, (No Diagnostic Substances)
Headquarters: Boston, Massachusetts
Fiscal year end: 12/31
Next earnings: 10/15, estimated

No member of Congress reported a trade in Compass Therapeutics CMPX in the past 90 days. Insiders filed 1 purchase and 0 sales on the open market over the same period, a net purchase of $2,850.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: +$2,850; Last 90 days · bought $2,850 · sold $0
Next earnings: 10/15; Estimated from the last four quarters

26-week trading

Common questions

Did Compass Therapeutics CMPX insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 1 purchase and 0 sales on the open market. Purchases came to $2,850.